Synopsis

Source of validity: Scientific
Rating (out of 5): 3

Digestive-resistant maltodextrin (DRM) is a type of soluble dietary fiber that is only partially digested in the human gastrointestinal tract, allowing it to reach the colon where it can exert prebiotic and stool-bulking effects. Several randomized controlled trials and open-label studies have evaluated its efficacy in improving stool frequency and consistency in children with constipation. The proposed mechanism involves DRM’s ability to increase fecal bulk and water content, as well as to modulate the gut microbiota, which can promote regular bowel movements.

A 2014 randomized, double-blind, placebo-controlled trial in children with chronic constipation found that daily supplementation with DRM significantly increased stool frequency compared to placebo, with some improvement in stool consistency. Other studies in both children and adults have shown similar benefits, though most pediatric studies are relatively small and of short duration. The European Food Safety Authority (EFSA) and other regulatory bodies recognize DRM as a safe source of dietary fiber, and its use for improving intestinal regularity is generally accepted.

While the overall evidence base is modest, it is positive, and DRM is considered a legitimate therapeutic option for managing constipation in children, particularly as a dietary adjunct. Larger and longer-term studies would help strengthen the evidence rating, but current data support its use as part of a fiber-enriched diet for pediatric constipation.

More about Digestion resistant Maltodextrin
More about Constipation (children)

Other ingredients used for Constipation (children)

Other health conditions supported by Digestion resistant Maltodextrin

Products containing Digestion resistant Maltodextrin